Pirfenidone Tablet, Film Coated
Product Images NDC 70954-869

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Pirfenidone (NDC 70954-869). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pirf-267mg (Pirf 267mg)

Pirf-267mg (Pirf 267mg)
This is a description of the medication Pirfenidone in tablet form. Each film-coated tablet contains 267 mg of Pirfenidone. It is a prescription medication and comes in a bottle containing 90 tablets. The usual dosage information can be found in the package insert. The medication should be kept out of reach of children. It should be stored at a temperature of 20° to 25°C (68° to 77°F), with excursions permitted between 15° to 30°C (59° to 86°F). This medication is distributed by ANI Pharmaceuticals, Inc. in Baudette, MN 56623. The expiration date mentioned is 10/2023.*
FDA Label Image

Pirf-801mg (Pirf 801mg)

Pirf-801mg (Pirf 801mg)
Product Description: This is a description for a medication called Pirfenidone in tablet form. Each tablet contains 801 mg of pirfenidone. It is a prescription-only medication and comes in a bottle containing 90 tablets. The recommended dosage should be consulted from the package insert. The medication should be stored at a temperature between 20°C to 25°C (68°F to 77°F), with temporary excursions allowed between 15°C to 30°C (59°F to 86°F). The product is distributed by ANI Pharmaceuticals, Inc. in Baudette, MN 56623. The expiry date of the product is 10/2023.*
FDA Label Image

Pirf-carton (Pirf Carton)

Pirf-carton (Pirf Carton)
This is a description of a medication called Pirfenidone Tablets. The medication comes in a package with a total of 270 tablets, divided into three bottles of 90 tablets each. Each film-coated tablet contains 267 mg of pirfenidone. The usual dosage, as well as information on how to administer the medication, can be found in the package insert. It is important to store the tablets between 20° to 25°C (68 to 77°F), with excursions allowed between 15° to 30°C (59°F to 86°F). The National Drug Code (NDC) for this medication is 70954-869-10. It is only available with a prescription and should be kept out of reach of children. The medication is distributed by ANI Pharmaceuticals, Inc., located in Baudette, MN 56623. The information was issued in October 2023.*
FDA Label Image

Pirfenidone Figure 1 (Pirfenidone Figure1)

FDA Label Image

Figure 11 (Pirfenidone Figure11)

Figure 11 (Pirfenidone Figure11)
The text appears to be a dosing schedule for Pirfenidone Tablets at a strength of 267 mg. The schedule is divided into three time periods: Days 1 to 7, Days 8 to 14, and Days 15 onwards. Each day during the first period, three pills should be taken in the morning, afternoon, and evening. During the second period, two pills should be taken at each meal for a total of seven pills per day. From Day 15 onwards, three pills should be taken at each meal, totaling eight pills per day.*
FDA Label Image

Figure 13 (Pirfenidone Figure13)

Figure 13 (Pirfenidone Figure13)
Take one brown 801 mg pirfenidone tablet three times each day. This dosing schedule involves taking one pill in the morning, one pill in the afternoon, and one pill in the evening. This regimen should be continued for at least 15 days onward.*
FDA Label Image

Pirfenidone Figure 2 (Pirfenidone Figure2)

FDA Label Image

Pirfenidone Figure 3 (Pirfenidone Figure3)

FDA Label Image

Pirfenidone Chemical Structure (Pirfenidone Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.